Recent progress in GLP-1 have centered on novel formulation methods, especially the emergence of rapidly breaking down tablets. These unique forms seek to enhance patient compliance and potentially provide faster absorption, contributing to better therapeutic results. Scientists suggest that this platform holds significant promise for the advanceme